リコンビナントタンパク質＿精製したリコンビナントタンパク質 » リコンビナント成長因子 » VEGF165, Human
VEGF165, Human

Biological Activity
VEGF-A165, Human (Cat. No. Z02689) stimulates cell proliferation of HUVEC cells. The ED50 for this effect is typically 1-5 ng/mL.

VEGF165, Human

GenScript product showed better activity compared to competitor P

VEGF165, Human

GenScript product showed better activity compared to competitor S

VEGF165, Human

GenScript product showed better activity compared to competitor R

VEGF165, Human

Recombinant VEGF165, Human (Z02689) was resolved by SDS-PAGE stained with coomassie blue, under reducing (R) and non-reducing (N) conditions, showing major bands at ~ 18-20 kDa and ~ 38-40 kDa, respectively. Multiple bands or smear in the gel are caused by glycosylation.

Lane 1: 2 µg of Z02689, reducing (R)
Lane 2: 2 µg of Z02689, non-reducing (N)
> 95% as analyzed by SDS-PAGE

VEGF165, Human

Vascular Endothelial Growth Factor (VEGF) is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascularized tissues, Vascular Endothelial Growth Factor (VEGF) plays a prominent role in normal and pathological angiogenesis. Substantial evidence implicates Vascular Endothelial Growth Factor (VEGF) in the induction of tumor metastasis and intra-ocular neovascular syndromes. Vascular Endothelial Growth Factor (VEGF) signals through the three receptors; fms-like tyrosine kinase (flt-1), KDR gene product (the murine homolog of KDR is the flk-1 gene product) and the flt4 gene product.
Z02689
¥18,125.00

Ask us a question
Product Introduction
Species Human
Protein Construction
VEGF165 (Ala27-Arg191)
Accession # P15692-4
Purity > 95% as analyzed by SDS-PAGE
Endotoxin Level < 0.5 EU/μg of protein by gel clotting method
Biological Activity ED50 of 1.0-5.0 ng/ml, measured by the dose-dependent stimulation of the proliferation of HUVEC cells, corresponding to a specific activity of 2.0 × 105-1.0 × 106 units/mg.
Expression System P. pastoris
Apparent Molecular Weight ~ 38-40 kDa, on SDS-PAGE under non-reducing conditions
~ 18-20 kDa, on SDS-PAGE under reducing conditions
Structure/form: Disulfide-linked homodimer
Formulation Lyophilized after extensive dialysis against 25 mM HEPES, 150 mM NaCl, pH 7.0.
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH₂O up to 100 μg/ml.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at lower than -70°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles.

Examples
  • VEGF165, Human
    • VEGF165, Human

    Biological Activity
    VEGF-A165, Human (Cat. No. Z02689) stimulates cell proliferation of HUVEC cells. The ED50 for this effect is typically 1-5 ng/mL.

  • VEGF165, Human
    • VEGF165, Human

    GenScript product showed better activity compared to competitor P

  • VEGF165, Human
    • VEGF165, Human

    GenScript product showed better activity compared to competitor S

  • VEGF165, Human
    • VEGF165, Human

    GenScript product showed better activity compared to competitor R

  • VEGF165, Human
    • VEGF165, Human

    Recombinant VEGF165, Human (Z02689) was resolved by SDS-PAGE stained with coomassie blue, under reducing (R) and non-reducing (N) conditions, showing major bands at ~ 18-20 kDa and ~ 38-40 kDa, respectively. Multiple bands or smear in the gel are caused by glycosylation.

    Lane 1: 2 µg of Z02689, reducing (R)
    Lane 2: 2 µg of Z02689, non-reducing (N)
    > 95% as analyzed by SDS-PAGE


Background
Target Background Vascular Endothelial Growth Factor (VEGF) is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascularized tissues, Vascular Endothelial Growth Factor (VEGF) plays a prominent role in normal and pathological angiogenesis. Substantial evidence implicates Vascular Endothelial Growth Factor (VEGF) in the induction of tumor metastasis and intra-ocular neovascular syndromes. Vascular Endothelial Growth Factor (VEGF) signals through the three receptors; fms-like tyrosine kinase (flt-1), KDR gene product (the murine homolog of KDR is the flk-1 gene product) and the flt4 gene product.
Synonyms VEGF-165; Vascular Endothelial Growth Factor 165; VPF; Folliculostellate cell-derived growth factor; Glioma-derived endothelial cell mitogen; Vascular Permeability Factor

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.